Your browser doesn't support javascript.
loading
Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.
Namikawa, Masashi; Kakizaki, Satoru; Kaira, Kyoichi; Tojima, Hiroki; Yamazaki, Yuichi; Horiguchi, Norio; Sato, Ken; Oriuchi, Noboru; Tominaga, Hideyuki; Sunose, Yutaka; Nagamori, Shushi; Kanai, Yoshikatsu; Oyama, Tetsunari; Takeyoshi, Izumi; Yamada, Masanobu.
Afiliación
  • Namikawa M; Department of Medicine and Molecular Science, Gunma University, Gunma, Japan.
  • Kakizaki S; Department of Internal Medicine, Kiryu Kosei General Hospital, Kiryu, Japan.
  • Kaira K; Department of Medicine and Molecular Science, Gunma University, Gunma, Japan.
  • Tojima H; Department of Medicine and Molecular Science, Gunma University, Gunma, Japan.
  • Yamazaki Y; Department of Oncology Clinical Development, Gunma University, Gunma, Japan.
  • Horiguchi N; Department of Medicine and Molecular Science, Gunma University, Gunma, Japan.
  • Sato K; Department of Medicine and Molecular Science, Gunma University, Gunma, Japan.
  • Oriuchi N; Department of Medicine and Molecular Science, Gunma University, Gunma, Japan.
  • Tominaga H; Department of Medicine and Molecular Science, Gunma University, Gunma, Japan.
  • Sunose Y; Department of Diagnostic Radiology and Nuclear Medicine, Gunma University, Gunma, Japan.
  • Nagamori S; Advanced Clinical Research Center, Fukushima Medical University, Fukushima, Japan.
  • Kanai Y; Department of Thoracic and Visceral Surgery, Gunma University, Gunma, Japan.
  • Oyama T; Division of Bio-system Pharmacology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Takeyoshi I; Division of Bio-system Pharmacology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Yamada M; Department of Diagnostic Pathology, Graduate School of Medicine, Gunma University, Gunma, Japan.
Hepatol Res ; 45(9): 1014-1022, 2015 Sep.
Article en En | MEDLINE | ID: mdl-25297701
ABSTRACT

AIM:

Amino acid transporters play an important role in tumor progression and survival of cancer cells. However, the prognostic significance of L-type amino acid transporter 1 (LAT1), system ASC amino acid transporter-2 (ASCT2) and xCT expression in patients with hepatocellular carcinoma (HCC) remains unclear. The aim of this study is to investigate the clinicopathological significance of these amino acid transporters in patients with HCC.

METHODS:

We examined 84 patients with surgically resected HCC. Tumor sections were stained by immunohistochemistry for LAT1, ASCT2, xCT, 4F2hc/CD98hc (4F2hc), Ki-67 and microvessel density (MVD) determined by CD34.

RESULTS:

LAT1, 4F2hc, ASCT2 and xCT were positively expressed in 61% (50/84), 77% (65/84), 63% (53/84) and 65% (55/84), respectively. Positive LAT1 expression was significantly associated with 4F2hc expression, Ki-67 and the serum albumin. By univariate analysis, LAT1 expression, disease stage and albumin had a significant relationship with overall survival. Tumor size, disease stage, portal vein invasion, albumin and α-fetoprotein had a significant relationship with progression-free survival. Multivariate analysis confirmed that LAT1 expression is an independent and significant prognostic factor for predicting worse outcome after surgery.

CONCLUSION:

LAT1 can serve as a significant prognostic marker for predicting negative prognosis after surgery.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Hepatol Res Año: 2015 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Hepatol Res Año: 2015 Tipo del documento: Article País de afiliación: Japón